Medical Developments International Limited announced that Penthrox® has been granted Marketing Authorisation in the Kingdom of Saudi Arabia (KSA). The Marketing Authorisation issued by the Saudi Food and Drug Administration (SFDA), is for Penthrox® to be used for Emergency relief of moderate to severe pain in conscious adult patients with trauma and associated pain.